The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Stroke Prevention in Atrial Fibrillation Study. Final results.
Abstract
BACKGROUND: Atrial fibrillation in the absence of rheumatic valvular disease is associated with a fivefold to sevenfold increased risk of ischemic stroke. METHODS AND MAIN RESULTS: The Stroke Prevention in Atrial Fibrillation Study, a multicenter, randomized trial, compared 325 mg/day aspirin (double-blind) or warfarin with placebo for prevention of ischemic stroke and systemic embolism (primary events), and included 1,330 inpatients and outpatients with constant or intermittent atrial fibrillation. During a mean follow-up of 1.3 years, the rate of primary events in patients assigned to placebo was 6.3% per year and was reduced by 42% in those assigned to aspirin (3.6% per year; p = 0.02; 95% confidence interval, 9-63%). In the subgroup of warfarin-eligible patients (most less than 76 years old), warfarin dose-adjusted to prolong prothrombin time to 1.3-fold to 1.8-fold that of control reduced the risk of primary events by 67% (warfarin versus placebo, 2.3% versus 7.4% per year; p = 0.01; 95% confidence interval, 27-85%). Primary events or death were reduced 58% (p = 0.01) by warfarin and 32% (p = 0.02) by aspirin. The risk of significant bleeding was 1.5%, 1.4%, and 1.6% per year in patients assigned to warfarin, aspirin, and placebo, respectively. CONCLUSIONS: Aspirin and warfarin are both effective in reducing ischemic stroke and systemic embolism in patients with atrial fibrillation. Because warfarin-eligible patients composed a subset of all aspirin-eligible patients, the magnitude of reduction in events by warfarin versus aspirin cannot be compared. Too few events occurred in warfarin-eligible patients to directly assess the relative benefit of aspirin compared with warfarin, and the trial is continuing to address this issue. Patients with nonrheumatic atrial fibrillation who can safely take either aspirin or warfarin should receive prophylactic antithrombotic therapy to reduce the risk of stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Coronary heart disease and atrial fibrillation: The Framingham Study
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90208-9 · Cited by 448
Influence of etiology of atrial fibrillation on incidence of systemic embolism
Hinton, R. C., Kistler, J. P., Fallon, J. T., Friedlich, A. L., & Fisher, C. M. (1977) · The American Journal of Cardiology · doi:10.1016/0002-9149(77)90064-9 · Cited by 247
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study
Wolf, P. A., Dawber, T. R., Thomas, E., & Kannel, W. B. (2011) · Neurology · doi:10.1212/01.wnl.0000407150.80523.a4 · Cited by 134
Risk Factors for Thromboembolic Complications in Chronic Atrial Fibrillation
Petersen, P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.819 · Cited by 130
Reducing risks of cerebral embolism.
Cm, F. (1979) · PubMed · Cited by 114
ATRIAL FIBRILLATION AND ANTITHROMBOTIC PROPHYLAXIS: A PROSPECTIVE META-ANALYSIS
Walker, M. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91332-9 · Cited by 23
Cited by
Items 101–145 of 145
Sick, P. B., Schuler, G., Hauptmann, K. E., Grube, E., Yakubov, S., Turi, Z. G., Mishkel, G., Almany, S., & Holmes, D. R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.035 · Cited by 351
Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., Deykin, D., & Brandt, J. T. (1998) · Chest · doi:10.1378/chest.114.5_supplement.445s · Cited by 349
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177031 · Cited by 345
Mügge, A., Kühn, H., Nikutta, P., Grote, J., G. Lopez, J. A., & Daniel, W. G. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90743-9 · Cited by 337
Ezekowitz, M. D., Connolly, S., Parekh, A., Reilly, P. A., Varrone, J., Wang, S., Oldgren, J., Themeles, E., Wallentin, L., & Yusuf, S. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.02.005 · Cited by 332
Gage, B. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230025025 · Cited by 329
Management of Atrial Fibrillation
Wood, A. J. J., & Pritchett, E. L. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261906 · Cited by 325
ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation
Khurshid, S., Friedman, S., Reeder, C., Di Achille, P., Diamant, N., Singh, P., Harrington, L. X., Wang, X., Al-Alusi, M. A., Sarma, G., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057480 · Cited by 322
Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall
Gage, B. F., Birman-Deych, E., Kerzner, R., Radford, M. J., Nilasena, D. S., & Rich, M. W. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.022 · Cited by 322
Atrial Fibrillation and Stroke: Concepts and Controversies
Hart, R. G., & Halperin, J. L. (2001) · Stroke · doi:10.1161/01.str.32.3.803 · Cited by 318
Guidelines on oral anticoagulation: third edition
(1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00715.x · Cited by 314
Marijon, E., Le Heuzey, J.-Y., Connolly, S., Yang, S., Pogue, J., Brueckmann, M., Eikelboom, J., Themeles, E., Ezekowitz, M., Wallentin, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000491 · Cited by 314
van Walraven, C., Hart, R. G., Connolly, S., Austin, P. C., Mant, J., Hobbs, F. D. R., Koudstaal, P. J., Petersen, P., Perez-Gomez, F., Knottnerus, J. A., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.526988 · Cited by 312
Hirsh, J., Fuster, V., Ansell, J., & Halperin, J. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00416-9 · Cited by 306
Gage, B. F., Boechler, M., Doggette, A. L., Fortune, G., Flaker, G. C., Rich, M. W., & Radford, M. J. (2000) · Stroke · doi:10.1161/01.str.31.4.822 · Cited by 302
Choice of prosthetic heart valve for adult patients
Rahimtoola, S. H. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02965-0 · Cited by 302
Gulløv, A. L., Koefoed, B. G., Petersen, P., Pedersen, T. S., Andersen, E. D., Godtfredsen, J., & Boysen, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1513 · Cited by 301
Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
Birman-Deych, E., Radford, M. J., Nilasena, D. S., & Gage, B. F. (2006) · Stroke · doi:10.1161/01.str.0000208294.46968.a4 · Cited by 301
Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms
Sharifi-Rad, J., Cruz-Martins, N., López-Jornet, P., Lopez, E. P.-F., Harun, N., Yeskaliyeva, B., Beyatli, A., Sytar, O., Shaheen, S., Sharopov, F., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6492346 · Cited by 297
Antithrombotic Therapy in Atrial Fibrillation
Laupacis, A., Albers, G., Dalen, J., Dunn, M. I., Jacobson, A. K., & Singer, D. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.579s · Cited by 294
Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., et al. (2007) · Europace · doi:10.1093/europace/eum191 · Cited by 293
Cairns, J. A., Connolly, S., McMurtry, S., Stephenson, M., & Talajic, M. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.007 · Cited by 292
Rash, A., Downes, T., Portner, R., Yeo, W. W., Morgan, N., & Channer, K. S. (2007) · Age and Ageing · doi:10.1093/ageing/afl129 · Cited by 285
Sato, H., Ishikawa, K., Kitabatake, A., Ogawa, S., Maruyama, Y., Yokota, Y., Fukuyama, T., Doi, Y., Mochizuki, S., Izumi, T., et al. (2006) · Stroke · doi:10.1161/01.str.0000198839.61112.ee · Cited by 282
The Incidence of Patent Foramen Ovale in 1,000 Consecutive Patients
Fisher, D. C., Fisher, E. A., Budd, J. H., Rosen, S. E., & Goldman, M. E. (1995) · Chest · doi:10.1378/chest.107.6.1504 · Cited by 280
Themistoclakis, S., Corrado, A., Marchlinski, F. E., Jais, P., Zado, E., Rossillo, A., Di Biase, L., Schweikert, R. A., Saliba, W. I., Horton, R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.039 · Cited by 276
Gitter, M. J., Jaeger, T. M., Petterson, T. M., Gersh, B. J., & Silverstein, M. D. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.725 · Cited by 276
Hart, R. G., Pearce, L. A., Miller, V. T., Anderson, D. C., Rothrock, J. F., Albers, G. W., & Nasco, E. (2000) · Cerebrovascular Diseases · doi:10.1159/000016023 · Cited by 265
Warfarin Anticoagulation and Outcomes in Patients With Atrial Fibrillation
Reynolds, M. W., Fahrbach, K., Hauch, O., Wygant, G., Estok, R., Cella, C., & Nalysnyk, L. (2004) · Chest · doi:10.1378/chest.126.6.1938 · Cited by 262
Friberg, J., Scharling, H., Gadsbøll, N., Truelsen, T., & Jensen, G. B. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.023 · Cited by 257
Sohara, H., Amitani, S., Kurose, M., & Miyahara, K. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00427-5 · Cited by 255
Lessons from the Stroke Prevention in Atrial Fibrillation Trials
Hart, R. G., Halperin, J. L., Pearce, L. A., Anderson, D. C., Kronmal, R. A., McBride, R., Nasco, E., Sherman, D. G., Talbert, R. L., Marler, J. R., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-10-200305200-00011 · Cited by 253
Aguilar, M. I., & Hart, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001927.pub2 · Cited by 252
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients
Marinigh, R., Lip, G. Y. H., Fiotti, N., Giansante, C., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.028 · Cited by 232
van Walraven, C., Hart, R. G., Wells, G. A., Petersen, P., Koudstaal, P. J., Gullov, A. L., Hellemons, B. S. P., Koefed, B. G., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.936 · Cited by 209
Davis, R. C., Hobbs, F. D. R., Kenkre, J. E., Roalfe, A. K., Iles, R., Lip, G. Y. H., & Davies, M. K. (2012) · Europace · doi:10.1093/europace/eus087 · Cited by 180
Matchar, D. B., Samsa, G. P., Cohen, S. J., Oddone, E. Z., & Jurgelski, A. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01131-2 · Cited by 141
Review of epidemiology and management of atrial fibrillation in developing countries
Nguyen, T. N., Hilmer, S. N., & Cumming, R. G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.184 · Cited by 139
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
MIKKELSEN, A. P., LINDHARDSEN, J., LIP, G. Y. H., GISLASON, G. H., TORP‐PEDERSEN, C., & OLESEN, J. B. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04853.x · Cited by 137
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Seward, J. B., Bailey, K. R., Iwasaka, T., & Tsang, T. S. M. (2005) · Stroke · doi:10.1161/01.str.0000185927.63746.23 · Cited by 103
Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults
Emdin, C. A., Anderson, S. G., Salimi-Khorshidi, G., Woodward, M., MacMahon, S., Dwyer, T., & Rahimi, K. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw053 · Cited by 73
Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment
Blackshear, J. L., Kopecky, S. L., Litin, S. C., Safford, R. E., & Hammill, S. C. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.2.150 · Cited by 67
Newer technologies for detection of atrial fibrillation
Zungsontiporn, N., & Link, M. S. (2018) · BMJ · doi:10.1136/bmj.k3946 · Cited by 53
Greason, K. L., Dearani, J. A., Theodoro, D. A., Porter, C.-B. J., Warnes, C. A., & Danielson, G. K. (2003) · Seminars in Thoracic and Cardiovascular Surgery Pediatric Cardiac Surgery Annual · doi:10.1016/s1092-9126(03)70009-x · Cited by 42
Metadata
- Venue
- Circulation
- Published
- 1991-08
- Volume
- 84
- Issue
- 2
- Pages
- 527-539
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2499224120
- Cited by
- 1,696
- References
- 7
- FWCI
- 54.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.